Monoclonal antibodies against topoisomerase I suppressed DNA relaxation and HIV-1 cDNA synthesis

Hybridoma. 2000 Aug;19(4):331-4. doi: 10.1089/027245700429882.

Abstract

Human immunodeficiency virus type 1 (HIV-1) virion is known to carry a number of cellular components including cellular topoisomerase I. Previously, we have demonstrated that topoisomerase I enhances HIV-1 cDNA synthesis in reverse transcription (RT) assays in vitro. In the present study, we have produced six monoclonal antibodies (MAbs) against human topoisomerase I. The MAbs suppressed nicking/closing of supercoiled DNA and cDNA synthesis in an endogenous reverse transcription (ERT) assay using a detergent-disrupted HIV-1 virion. Thus, the results suggest that topoisomerase I plays an important role in RNA-directed DNA polymerization.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Monoclonal / pharmacology*
  • Antibody Specificity / immunology
  • Blotting, Southern
  • Cell Line
  • DNA Replication / drug effects*
  • DNA Topoisomerases, Type I / immunology*
  • DNA Topoisomerases, Type I / isolation & purification
  • DNA, Complementary / biosynthesis*
  • DNA, Viral / drug effects*
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • HIV-1 / drug effects*
  • HIV-1 / genetics
  • HeLa Cells
  • Humans
  • Mice
  • Mice, Inbred BALB C
  • RNA, Viral / biosynthesis
  • Reverse Transcriptase Polymerase Chain Reaction
  • Transfection
  • Virus Replication

Substances

  • Antibodies, Monoclonal
  • DNA, Complementary
  • DNA, Viral
  • RNA, Viral
  • DNA Topoisomerases, Type I